Effect of Kuvan on Neurocognitive Function, Blood Phenylalanine Level, Safety, and Pharmacokinetics in Children With PKU
A Phase 1 Study to Evaluate Effects of Sapropterin Dihydrochloride on QTc Intervals in Healthy Adult Subjects
Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003)
The Effectiveness of Kuvan in Amish PKU Patients
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Kuvan®’s Effect on the Cognition of Children With Phenylketonuria
Evaluation of Behavior, Executive Function, Neurotransmitter Function and Genomic Expression Kuvan Nonresponders
You're leaving the BioMarin Clinical Trials website.
This will take you to BioMarin.com, our global corporate website. Some of the information on BioMarin.com is intended for U.S. audiences only.
Leave this website
Close
You’re leaving the BioMarin Clinical Trials website.
Links to sites outside of this website are provided as a resource to the viewer. BioMarin accepts no responsibility for the content of linked sites.
Leave this website
Close
